乳房假体新型蛋白质组学检测揭示结合差异显著的蛋白质:对表面涂层与生物相容性的意义
研究从乳房缩小术患者获取创面液体,与13种市售乳房假体表面孵育,建立原位消化洗脱结合蛋白的检测方法,共鉴定出822种结合蛋白。纤维蛋白原、白蛋白及补体C3、C5、因子H在不同假体表面的结合存在显著差异。
要点
- 建立乳房假体表面蛋白结合的新型检测方法,共鉴定822种结合蛋白。
- 纤维蛋白原与白蛋白在不同假体表面的结合差异显著(P < 0.0001)。
- 补体C3、C5及因子H在不同假体表面的结合亲和力差异显著(P < 0.05)。
核心结论
- 研究建立了乳房假体蛋白结合的新型检测方法,并证实来源于乳腺组织创面液的相关蛋白在不同假体表面具有显著不同的结合亲和力。
研究设计与样本
- 从接受乳房缩小术的女性获取创面液体,与13种市售乳房假体表面接触孵育。
- 优化原位消化技术以洗脱结合蛋白,样本在Orbitrap elite分析仪上分析,蛋白在Mascot Demon中鉴定并在Progenesis中分析。
主要发现
- 共鉴定出822种结合于假体表面的蛋白质。
- 细胞外蛋白是最丰富的本体类别,其次是细胞内蛋白。
- 促炎蛋白纤维蛋白原与抗炎蛋白白蛋白在不同假体表面之间的结合差异显著(P < 0.0001)。
- 补体C3、C5及因子H对所研究假体的结合亲和力差异显著(P < 0.05)。
关键数值与推荐
- 纤维蛋白原与白蛋白在不同假体表面之间的结合差异显著(P < 0.0001)。
- 补体C3、C5及因子H在不同假体表面之间的结合亲和力差异显著(P < 0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Silicone elastomer, a ubiquitous biomaterial and main constituent of breast implants, has been used for breast augmentation and reconstruction for over 50 years. Breast implants have direct local and purported systemic effects on normal tissue homeostasis dictated by the chemical and physical presence of the implant. OBJECTIVES: Protein adsorption has been demonstrated to be a key driver of local reactions to silicone. We sought to develop an assay and identify the proteins that coat implants during breast implantation. METHODS: Wound fluid was salvaged from women who had undergone breast reduction and incubated in contact with the surface of 13 commercially available implant surfaces. An in situ digestion technique was optimized to elute bound proteins. Samples were analyzed on an Orbitrap elite analyser, proteins identified in Mascot Demon and analyzed in Progenesis. RESULTS: A total of 822 proteins were identified, bound to the surfaces of the implants. Extracellular proteins were the most abundant ontology, followed by intracellular proteins. Fibrinogen, a proinflammatory protein and Albumin, an anti-inflammatory protein had significant (P < 0.0001) binding differences between the surfaces studied. Complement C3, C5, and factor H were also shown to have significantly different binding affinities for the implants included in the study (P < 0.05). CONCLUSIONS: We have developed a novel assay of breast implant protein binding and demonstrated significant binding affinities for relevant proteins derived from breast tissue wound fluid.
引用
- Barr SP, Hill EW, Bayat A, et al. Novel Proteomic Assay of Breast Implants Reveals Proteins With Significant Binding Differences: Implications for Surface Coating and Biocompatibility. Aesthet Surg J. 2018. PMID: 29590306. doi:10.1093/asj/sjy018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。